Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): a potential imaging ligand for D-2 dopamine receptors in SPECT.
Life Sci. 1988;42(21):2097-104. doi: 10.1016/0024-3205(88)90123-3.
Life Sci. 1988.
PMID: 3260318
The toxicity and mutagenicity of S-3-iodo-N-(1-ethyl-2-pyrrolidinyl)methyl-2-hydroxy-6-methoxybenzamide (IBZM), a new CNS D-2 dopamine receptor imaging agent.
Kostyniak PJ, Brenner JS, Maccubbin AE, Nakeeb S, Kasliwal R, Kung HF.
Kostyniak PJ, et al.
Drug Chem Toxicol. 1988;11(4):433-42. doi: 10.3109/01480548809018113.
Drug Chem Toxicol. 1988.
PMID: 2977324
Item in Clipboard
Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
Singhaniyom W, Tsai YF, Brücke T, McLellan CA, Cohen RM, Kung HF, Chiueh CC.
Singhaniyom W, et al.
Brain Res. 1988 Jun 21;453(1-2):393-6. doi: 10.1016/0006-8993(88)90186-2.
Brain Res. 1988.
PMID: 2969766
Item in Clipboard
Cite
Cite